Clinical trial
A Phase 3, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects With Macular Edema Associated With Non-infectious Uveitis
NCT02595398 is registered in ClinicalTrials.gov with Clearside Biomedical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects With Macular Edema Associated With Non-infectious Uveitis
- Lead sponsor
- Clearside Biomedical, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 17, 2015
- Completion date
- January 18, 2018
- Enrollment
- 160 (actual)
- Sites
- 64
Conditions
As the registry lists them; a condition with its own page is linked.